Breaking News, Collaborations & Alliances

Evotec Reaches Ono Ion Channel Milestone

Discover collaboration began in April 2009 for molecules targeting CV, CNS, urology

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Evotec AG has received a milestone payment for reaching specific success criteria in an ion channel research collaboration with Ono Pharmaceutical Co. This project was initiated in October 2009 to identify small molecules targeting an ion channel implicated in cardiovascular, CNS and urological diseases. The companies have successfully identified multiple compounds meeting various criteria in activity, selectivity and pharmacokinetic characteristics. Evotec and Ono will continue this research c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters